Syphilis Testing Market, By Type of Syphilis (Primary and Secondary Syphilis and Latent and Tertiary Syphilis), By Test Methodology (Serological Tests (Non-Treponemal Tests (e.g., RPR, VDRL), Treponemal Tests (e.g., TPHA, FTA-ABS)) and Molecular Diagnostics (Nucleic Acid Amplification Tests (NAATs), Polymerase Chain Reaction (PCR))), By Location of Testing (Laboratory Testing and Point-of-Care (POC) Testing), By Specimen Type (Serum/Plasma, Whole Blood, Oral Fluid, and Dried Blood Spot (DBS)), By Product Format (Diagnostic Kits, Reagents and Consumables, and Instruments and Analyzers), By Technology (Enzyme-Linked Immunosorbent Assay (ELISA), Chemiluminescent Immunoassay (CLIA), Lateral Flow Assays (LFA), Rapid Plasma Reagin (RPR), and Treponemal Particle Agglutination (TPPA)), By End User (Hospitals, Diagnostic Laboratories, Point-of-Care (POC) Settings, Home Care/Self-Testing, and Others (Academic and Research Institutes)), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)